Sign in

CIK 0001574232

  • Non-accelerated filer

Addex Therapeutics Ltd.

Sign in to watch
Ticker
ADXN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 228841555
Business address
CHEMIN DES MINES 9, GENEVA, Switzerland, CH-1202
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Hill Raymond George Director Grant or award · Stock-option (Right to Buy) +1,319,996 1,593,103
2026-11-11 Lawton Vincent Michael Director Grant or award · Stock-option (Right to Buy) +1,885,708 2,387,306
2026-11-11 Lawton Vincent Michael Director Grant or award · Stock-option (Right to Buy) +942,854 1,444,452
2026-11-11 Mills Roger CHIEF MEDICAL OFFICER Grant or award · Stock-option (Right to Buy) +942,854 992,854
2026-11-11 Hill Raymond George Director Grant or award · Stock-option (Right to Buy) +942,854 1,215,961
2026-11-11 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +3,771,415 4,374,323
2026-11-11 Nunn Jason Raleigh Director Grant or award · Stock-option (Right to Buy) +942,854 992,854
2026-11-11 Manke Isaac Director Grant or award · Stock-option (Right to Buy) +942,854 992,854
2026-11-11 Dyer Timothy Mark CHIEF EXECUTIVE OFFICER Grant or award · Stock-option (Right to Buy) +18,857,075 22,226,871
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −37,770 565,138
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +37,770 602,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −59,530 543,378
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +59,530 602,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −10,000 592,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +10,000 602,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −30,000 572,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +30,000 602,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −65,620 537,288
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Grant or award · Stock-option (Right to Buy) +65,620 602,908
2026-09-02 Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER Returned to the company · Stock-option (Right to Buy) −90,529 512,379

Page 1 of 3 · 53 trades